The Combination Of He4 And Ca-125 Is Superior To Either Marker Alone For Monitoring Women With Ovarian Cancer

A. Samborski, A.M. Blackman,M.C. Miller,S. MacLaughlan David, A.L. Jackson,E. Eklund, G. Messerlian,R.G. Moore

GYNECOLOGIC ONCOLOGY(2020)

Cited 0|Views19
No score
Abstract
Objective: CA-125 is the current gold standard biomarker for monitoring women with epithelial ovarian cancer (EOC). Human epididymal protein 4 (HE4) is a novel biomarker elevated in 80% of EOC patients. The objective of this trial was to examine the utility of HE4 for monitoring women with EOC.
More
Translated text
Key words
ovarian cancer,he4
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined